First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation ...
GE Healthcare announced the US Food and Drug Administration (FDA) has approved DaTscan (Ioflupane I 123 Injection), a radiopharmaceutical agent intended for use with Single Photon Emission Computed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results